ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.826,12
0,15%
Brent Oil
80,76
-0,66%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Harmony Biosciences Holdings Inc (HRMY)

  7. Harmony Biosciences Holdings Inc (HRMY) Notícias

HRMY

Harmony Biosciences (HRMY)

Harmony Biosciences Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:HRMY
DataHoraFonteTítuloCódigoCompanhia
31/05/202409:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
29/05/202418:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRMYHarmony Biosciences Holdings Inc
28/05/202409:05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
30/04/202408:05GlobeNewswire Inc.Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare EpilepsyNASDAQ:HRMYHarmony Biosciences Holdings Inc
30/04/202408:00PR Newswire (US)Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS AssetsNASDAQ:HRMYHarmony Biosciences Holdings Inc
16/04/202409:05PR Newswire (US)HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024NASDAQ:HRMYHarmony Biosciences Holdings Inc
11/04/202409:05PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONISTNASDAQ:HRMYHarmony Biosciences Holdings Inc
03/04/202409:05PR Newswire (US)HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROMENASDAQ:HRMYHarmony Biosciences Holdings Inc
26/03/202409:05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
08/03/202418:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
28/02/202419:16Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
28/02/202410:05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESNASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202418:14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202410:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202409:30GlobeNewswire Inc.Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business UpdatesNASDAQ:HRMYHarmony Biosciences Holdings Inc
21/02/202410:05PR Newswire (US)U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSYNASDAQ:HRMYHarmony Biosciences Holdings Inc
20/02/202410:05PR Newswire (US)HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROMENASDAQ:HRMYHarmony Biosciences Holdings Inc
13/02/202421:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
08/02/202410:05PR Newswire (US)HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024NASDAQ:HRMYHarmony Biosciences Holdings Inc
26/01/202418:58Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
08/01/202410:05PR Newswire (US)HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCENASDAQ:HRMYHarmony Biosciences Holdings Inc
03/01/202410:05PR Newswire (US)HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
07/12/202318:06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
07/12/202310:05PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1NASDAQ:HRMYHarmony Biosciences Holdings Inc
05/12/202310:05PR Newswire (US)HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETINGNASDAQ:HRMYHarmony Biosciences Holdings Inc
16/11/202310:05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
15/11/202310:05PR Newswire (US)HARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING COMPANIES IN NORTH AMERICA ON THE 2023 DELOITTE TECHNOLOGY FAST 500™NASDAQ:HRMYHarmony Biosciences Holdings Inc
08/11/202310:05PR Newswire (US)HARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD OF DIRECTORSNASDAQ:HRMYHarmony Biosciences Holdings Inc
31/10/202309:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HRMYHarmony Biosciences Holdings Inc
31/10/202308:30GlobeNewswire Inc.Harmony Biosciences Reports Strong Third Quarter 2023 Financial ResultsNASDAQ:HRMYHarmony Biosciences Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:HRMY

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
OIBR3
OI ON
BOV
ENAT3
ENAUTA ON
BOV
RNEW4
RENOVA PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados